These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 20956135

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Management of pulmonary arterial hypertension in children.
    Roofthooft MT, van Loon RL, Berger RM.
    Paediatr Respir Rev; 2010 Dec; 11(4):240-5. PubMed ID: 21109183
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Prostanoid therapy for pulmonary arterial hypertension.
    Badesch DB, McLaughlin VV, Delcroix M, Vizza CD, Olschewski H, Sitbon O, Barst RJ.
    J Am Coll Cardiol; 2004 Jun 16; 43(12 Suppl S):56S-61S. PubMed ID: 15194179
    [Abstract] [Full Text] [Related]

  • 26. [Pulmonary arterial hypertension in childhood].
    Douwes JM, van Loon RL, Roothooft MT, Berger RM.
    Ned Tijdschr Geneeskd; 2011 Jun 16; 155(49):A3901. PubMed ID: 22166180
    [Abstract] [Full Text] [Related]

  • 27. Comparative effectiveness and safety of drug therapy for pulmonary arterial hypertension: a systematic review and meta-analysis.
    Coeytaux RR, Schmit KM, Kraft BD, Kosinski AS, Mingo AM, Vann LM, Gilstrap DL, Hargett CW, Heidenfelder B, Dolor RJ, McCrory DC.
    Chest; 2014 May 16; 145(5):1055-1063. PubMed ID: 24371842
    [Abstract] [Full Text] [Related]

  • 28. Oral targeted therapies in the treatment of pulmonary arterial hypertension: a meta-analysis of clinical trials.
    Zheng YG, Ma H, Hu EC, Liu G, Chen G, Xiong CM.
    Pulm Pharmacol Ther; 2014 Dec 16; 29(2):241-9. PubMed ID: 25173912
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Combination therapy in pulmonary arterial hypertension.
    Pugh ME, Hemnes AR, Robbins IM.
    Clin Chest Med; 2013 Dec 16; 34(4):841-55. PubMed ID: 24267308
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Combination therapy for pulmonary arterial hypertension: still more questions than answers.
    Hoeper MM, Dinh-Xuan AT.
    Eur Respir J; 2004 Sep 16; 24(3):339-40. PubMed ID: 15358685
    [No Abstract] [Full Text] [Related]

  • 36. Endothelin receptor antagonists in pulmonary arterial hypertension.
    Channick RN, Sitbon O, Barst RJ, Manes A, Rubin LJ.
    J Am Coll Cardiol; 2004 Jun 16; 43(12 Suppl S):62S-67S. PubMed ID: 15194180
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Prostanoid therapy for pulmonary arterial hypertension.
    Strauss WL, Edelman JD.
    Clin Chest Med; 2007 Mar 16; 28(1):127-42; ix. PubMed ID: 17338932
    [Abstract] [Full Text] [Related]

  • 39. Pulmonary arterial hypertension associated with a congenital heart defect: advanced medium-term medical treatment stabilizes clinical condition.
    Duffels M, van Loon L, Berger R, Boonstra A, Vonk-Noordegraaf A, Mulder B.
    Congenit Heart Dis; 2007 Mar 16; 2(4):242-9. PubMed ID: 18377475
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.